Effects of lamivudine on the function of dendritic cells derived from patients with chronic hepatitis B virus infection

World Journal of Gastroenterology

Volumn 13, Issue 34, 2007, Pages 4641-4645

  Zheng, Peng Yuan ^a   Zhang, Dong Yun ^b   Lu, Gao Feng ^a   Yang, Ping Chang ^c   Qi, Yuan Ming ^a   Wang, Bai Sheng ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Luohe Medical College   (China)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Chronic hepatitis B; Dendritic cell; Immune; Lamivudine

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; LAMIVUDINE; T6 ANTIGEN;

ARTICLE; ASIAN; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LYMPHOCYTE PROLIFERATION; MICROSCOPY; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; NITROBLUE TETRAZOLIUM TEST; PHENOTYPE; SUPERNATANT;

EID: 34648834777     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i34.4641     Document Type: Article

References (18)

1. Hilleman MR. Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 2003; 21: 4626-4649
2. Akbar SM, Inaba K, Onji M. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen. Immunology 1996; 87: 519-527
3. Moll H. Dendritic cells as a tool to combat infectious diseases. Immunol Lett 2003; 85: 153-157
4. Wolters LM, Niesters HG, de Man RA. Nucleoside analogues for chronic hepatitis B. Eur J Gastroenterol Hepatol 2001; 13: 1499-1506
5. Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, Scognamiglio P, Boehme R, Panebianco R, Fiaccadori F, Ferrari C. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998; 102: 968-975
6. Beckebaum S, Cicinnati VR, Zhang X, Ferencik S, Frilling A, Grosse-Wilde H, Broelsch CE, Gerken G. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 2003; 109: 487-495
7. Beckebaum S, Cicinnati VR, Dworacki G, Muller-Berghaus J, Stolz D, Harnaha J, Whiteside TL, Thomson AW, Lu L, Fung JJ, Bonham CA. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 2002; 104: 138-150
8. Kurose K, Akbar SM, Yamamoto K, Onji M. Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells. Immunology 1997; 92: 494-500
9. Akbar SM, Inaba K, Onji M. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen. Immunology 1996; 87: 519-527
10. Hasebe A, Akbar SM, Furukawa S, Horiike N, Onji M. Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses. Clin Exp Immunol 2005; 139: 35-42
11. Foti M, Granucci F, Ricciardi-Castagnoli P. Dendritic cell interactions and cytokine production. Ernst Schering Res Found Workshop 2006: 61-80
12. Kunitani H, Shimizu Y, Murata H, Higuchi K, Watanabe A. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J Hepatol 2002; 36: 734-741
13. Szabolcs P, Moore MA, Young JW. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol 1995; 154: 5851-5861
14. Rodriguez-Fernandez JL, Corbi AL. Adhesion molecules in human dendritic cells. Curr Opin Investig Drugs 2005; 6: 1103-1111
15. Rouard H, Leon A, Klonjkowski B, Marquet J, Tenneze L, Plonquet A, Agrawal SG, Abastado JP, Eloit M, Farcet JP, Delfau-Larue MH. Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity. J Immunol Methods 2000; 241: 69-81
16. Seager Danciger J, Lutz M, Hama S, Cruz D, Castrillo A, Lazaro J, Phillips R, Premack B, Berliner J. Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. J Immunol Methods 2004; 288: 123-134
17. Kolb-Maurer A, Brocker EB. The role of dendritic cells during infection. J Dtsch Dermatol Ges 2003; 1: 438-442
18. Talmor M, Mirza A, Turley S, Mellman I, Hoffman LA, Steinman RM. Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur J Immunol 1998; 28: 811-817